why tirzepatide is better than semaglutide vs Tirzepatide Outperforms Semaglutide in Weight

increasing in prevalence as the population ages and becomes more obese and more sedentary

& Gomis, R

Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges

Nov 2019;25(6):594-601

Its early data showing up to 24% body weight reduction suggests a different dose-response curve from current semaglutide options

The solution should be perfectly transparent